Equity Offerings
-
-
-
-
-
-
-
Summit Therapeutics to Host Second Quarter 2026 Financial Results & Operational Progress Call on July 23, 2026
-
-
-
-
-
-
-
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2026
-
-
-
-
-
-
-
FDA accepts Summit Therapeutics BLA for lung cancer drug ivonescimab
-
-
-
-
-
-
-
Summit Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Summit Therapeutics raises $500 million in private placement
-
-
-
-
-
-
-
Summit Therapeutics to Host ESMO Data Update & Third Quarter Earnings Call on October 20, 2025
-
-
-
-
-
-
-
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025
-
13,099 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

